(27 days)
No
The summary describes a hardware modification (new C-Arm) to an existing X-ray system. There is no mention of AI, ML, or related concepts in the device description, intended use, or performance studies. The focus is on mechanical and electrical equivalence and compliance with safety standards.
No
The device is described as an angiographic X-ray system used for diagnostic imaging and interventional procedures, which are investigative or procedural rather than therapeutic.
Yes
Explanation: The "Intended Use / Indications for Use" section explicitly states that "The Trinias is an angiographic X-ray system, which is used for diagnostic imaging and interventional procedures."
No
The device description explicitly details hardware components like a ceiling-mounted C-Arm (MH-700), X-ray high voltage unit, X-ray tube unit, X-ray image recording unit (FPD), and a catheterization table. The submission also includes testing and compliance with standards related to hardware safety and performance (e.g., IEC 60601 series).
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is an "angiographic X-ray system, which is used for diagnostic imaging and interventional procedures." This involves imaging the inside of the body using X-rays, not testing samples of bodily fluids or tissues in vitro (outside the body).
- Device Description: The description focuses on the physical components of an X-ray system (C-Arm, X-ray tube, image recording unit, etc.) used for imaging patients.
- Input Imaging Modality: The input modality is "X-ray," which is an imaging technique applied to the patient, not a method for analyzing samples.
- Anatomical Site: The anatomical sites listed are parts of the human body, indicating the device is used on a living patient.
- Performance Studies: The performance studies described relate to software validation, cybersecurity, radiation safety, and compliance with standards for medical electrical equipment and X-ray systems. These are typical for imaging devices, not IVDs.
IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. This device operates by generating and detecting X-rays that pass through the patient's body.
N/A
Intended Use / Indications for Use
The Trinias is an angiographic X-ray system, which is used for diagnostic imaging and interventional procedures. The Trinias is intended to be used for cardiac angiography, neurovascular angiography, abdominal angiography, peripheral angiography, rotational angiography, multi-purpose angiography and whole body radiographic/fluoroscopic procedures.
Product codes
OWB
Device Description
This notification is for a modification is the addition of the new MH-700 (ceiling mounted C-Arm). This is the functional equivalent of previous C-Arm MH-400. All options declared under K203535 remain available. The Lateral Angiographic C-arm Support MH-700 allows examination of a patient by fluoroscopy or radiography from different angles with the patient kept in a horizontal position in combination with a Frontal C-arm Support MH-600, an X-ray high voltage unit, X-ray tube unit, X-ray image recording unit (FPD), digital angiography system, catheterization table, etc. The range of available digital receptor panels remains unchanged from our predicate K203535. For installation, ceiling strength is important because the total weight of MH-700 exceeds 1200 kg. The MH-700 features faster movement speeds as compared to the previous model, the MH-400.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-Ray
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The results of bench and standards testing indicates that the modified device is as safe and effective as the predicate device. Proper system operation is fully verified upon installation. Most of the components employed are identical to the predicate device.
Software was validated according to the FDA Guidance: Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document issued on: May 11, 2005. Because the system uses Wi-Fi and Ethernet, we observed the recommendations contained in the FDA Guidance Document: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices Guidance for Industry and Food and Drug Administration Staff Document Issued on: October 2, 2014. The digital panel software employed was already reviewed by FDA. Labeling was developed and information provided in accordance with this FDA Guidance Document: Pediatric Information for X-ray Imaging Device Premarket Notifications, Guidance for Industry and Food and Drug Administration Staff, November 2017. Labeling also includes reference to the Image Gently website (http://www.imagegently.org/). Because the device contains wireless technology, we consulted Radio Frequency Wireless Technology in Medical Devices - Guidance for Industry and FDA Staff, AUGUST 2013 and we incorporated those recommendations into our labeling.
This device has been tested and is certified to comply with the US Radiation Safety Performance Standards as listed in the table above. Performance and safety testing was conducted by third party NRTL certified testing laboratories and the device was found to comply with the following FDA recognized standards:
- US Performance Standard: 21CFR1020.30, 21CFR1020.31 and 21CFR2020.32
- IEC 60601-1: 2005 + CORR. 1:2006 + CORR. 2:2007 + AM1:2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance FDA 19-4
- IEC 60601-1-2:2014 Collateral Standard: Electromagnetic disturbances Requirements and tests FDA . 19-8
- IEC 60601-1-3:2008 + A1:2013 Medical electrical equipment - Part 1-3: General requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic Xray equipment FDA 12-269
- IEC 60601-1-6:2010 + A1:2013 Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability FDA 5-89
- IEC 60601-2-43:2010 +A1:2017 +A2:2019 Particular requirements for the basic safety and essential performance of X-ray equipment for interventional procedures FDA 12-329
- Additionally evaluated in accordance with
- IEC 62366: 2007 + A1: 2014 Medical devices - Part 1: Application of usability engineering to medical devices FDA 5-114
- IEC 62304: 2006 Medical device software - Software life cycle processes FDA 13-79
- EN 60601-1:2006 + A11:2011 + A1:2013 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance
- EN 60601-1-3:2008 + A1:2013 + A11:2016 Medical electrical equipment Part 1-3: General requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic X-ray equipment
- EN 60601-1-6:2010 + A1:2015 Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability
- EN 60601-2-43:2010 + A1:2018 Medical electrical equipment - Particular requirements for the basic safety and essential performance of X-ray equipment for interventional procedures
- EN 62304:2006 Medical device software - Software life cycle processes
- ANSI/AAMI ES60601-1:2005 + A2:2010 + A1:2012
Clinical testing was not deemed to show substantial equivalence. We relied on non-clinical testing and compliance with standards.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1650 Image-intensified fluoroscopic x-ray system.
(a)
Identification. An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health and Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
July 28, 2022
Shimadzu Corporation Medical Systems Division % Daniel Kamm Principal Engineer Kamm & Associates 8870 Ravello Ct NAPLES FL 34114
Re: K221922
Trade/Device Name: Trinias Regulation Number: 21 CFR 892.1650 Regulation Name: Image-Intensified Fluoroscopic X-Ray System Regulatory Class: Class II Product Code: OWB Dated: June 30, 2022 Received: July 1, 2022
Dear Daniel Kamm:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Laurel Burk, Ph.D. Assistant Director Diagnostic X-Ray Systems Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K221922
Device Name Trinias
Indications for Use (Describe)
The Trinias is an angiographic X-ray system, which is used for diagnostic imaging and interventional procedures. The Trinias is intended to be used for cardiac angiography, neurovascular angiography, abdominal angiography, peripheral angiography, rotational angiography, multi-purpose angiography and whole body radiographic/fluoroscopic procedures
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
|---|---|
| ---------------------------------------------- | --------------------------------------------- |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary: 510(k) Number K221922
HIMADZI
Shimadzu Corporation 1, Nishinokyo-Kuwabaracho, Nakagyo-ku, Kyoto, 604-8511, Japan Registration Number: 8030233 Phone: +81-75-823-1305 Fax: +81-75-823-1377
Date Prepared: July 26, 2022
Koichi Kataoka, General Manager, Quality Assurance Department, Medical Systems Division Contact:
1. Identification of the Device:
Trade/Device Names: Trinias Regulation Number: 21CFR892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: II Product Code: OWB Common/Usual Name: Interventional Fluoroscopic X-Ray System
2. Equivalent legally marketed device: K203535
Trade/Device Name: Trinias Manufacturer: Shimadzu. Regulation Number: 21CFR892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: II Product Code: OWB Interventional Fluoroscopic X-Ray System Common/Usual Name:
-
- Indications for Use: The Trinias is an angiographic X-ray system which is used for diagnostic imaging and interventional procedures. The Trinias is intended to be used for cardiac angiography, neurovascular angiography, abdominal angiography, peripheral angiography, rotational angiography, multi-purpose angiography and whole body radiographic/fluoroscopic procedures.
-
- Description of the Device: This notification is for a modification is the addition of the new MH-700 (ceiling mounted C-Arm). This is the functional equivalent of previous C-Arm MH-400. All options declared under K203535 remain available. The Lateral Angiographic C-arm Support MH-700 allows examination of a patient by fluoroscopy or radiography from different angles with the patient kept in a horizontal position in combination with a Frontal C-arm Support MH-600, an X-ray high voltage unit, X-ray tube unit, X-ray image recording unit (FPD), digital angiography system, catheterization table, etc. The range of available digital receptor panels remains unchanged from our predicate K203535. For installation, ceiling strength is important because the total weight of MH-700 exceeds 1200 kg. The MH-700 features faster movement speeds as compared to the previous model, the MH-400.
-
- Safety and Effectiveness, comparison to predicate device. The results of bench and standards testing indicates that the modified device is as safe and effective as the predicate device. Proper system operation is fully verified upon installation. Most of the components employed are identical to the predicate device.
4
| Trinias K203535 | Modified Trinias | |
|---|---|---|
| Indications for | ||
| Use: | The Trinias is an angiographic X-ray system | |
| which is used for diagnostic imaging and | ||
| interventional procedures. The Trinias is | ||
| intended to be used for cardiac angiography, | ||
| neurovascular angiography, abdominal | ||
| angiography, peripheral angiography, rotational | ||
| angiography, multi-purpose angiography and | ||
| whole body radiographic/fluoroscopic | ||
| procedures. | The Trinias is an angiographic X-ray system | |
| which is used for diagnostic imaging and | ||
| interventional procedures. The Trinias is | ||
| intended to be used for cardiac angiography, | ||
| neurovascular angiography, abdominal | ||
| angiography, peripheral angiography, | ||
| rotational angiography, multi-purpose | ||
| angiography and whole body | ||
| radiographic/fluoroscopic procedures. | ||
| Indications statement has not changed. | ||
| Patient Table | KS-100, table top can tilt. | Same as predicate |
| Bi-plane C-Arms | ||
| Biplane C-arm | ||
| (Combines a | ||
| floor mounted C- | ||
| arm with a ceiling | ||
| mounted C-arm) | MH-300 plus MH-400 | MH-600 plus MH-700 (MH-700 is new) |
| (MH-600 previously cleared) | ||
| Picture of | ||
| equivalent | ||
| assembly | Image: MH-300/MH-400 | Image: MH-600/MH-700 |
| Comparison of Equivalent Assemblies: MH-400 vs MH-700 | ||
| Lateral C-arm | MH-400 (K123508) | MH-700 |
| Mounting | Ceiling | Same |
| Variation of | ||
| position | LL position / RL Position | Same |
| LL position | ||
| Primary angle) | ||
| C-arm rotation | ||
| range and Speed | "LAO120 - PA0 | |
| Max 15deg/sec" | ||
| (LAO=Left Anterior Oblique) | ||
| (PA= Postero-Anterior projection) | "LAO120 - PA0 | |
| Max 25deg/sec" Faster response | ||
| RL position | ||
| Primary angle) | ||
| C-arm rotation | ||
| range and Speed | "PA0 - RAO120 | |
| Max 15deg/sec" | ||
| (RAO= Right Anterior Oblique) | "PA0 - RAO120 | |
| Max 25deg/sec" Faster response | ||
| Trinias K203535 | Modified Trinias | |
| LL position | ||
| Secondary | ||
| Angle C-arm | ||
| rotation range | ||
| and Speed | "CRAN45 - CAUD45 | |
| Max 15deg/sec" | ||
| (CRAN=Caudo-Cranial projection) | ||
| (CAUD=Cranio-Caudal projection) | "CRAN45 - CAUD45 | |
| Max 25deg/sec" | ||
| Faster response | ||
| RL position | ||
| Secondary Angle | ||
| C-arm rotation | ||
| range and Speed | "CRAN30°~CAUD30° | |
| Max 15deg/sec" | "CRAN45 - CAUD45 | |
| Max 25deg/sec" | ||
| Faster response | ||
| SID range/speed | 95cm - 125cm , 8cm/sec max | 95cm - 125cm, 10cm/sec max |
| Faster response | ||
| Digital Image | ||
| Processor | DAR-9500f | Same as predicate |
| Digital X-Ray Receptor Panels (No changes) Shimadzu Reference/Manufacturer Model | ||
| SIZE: 8" x 8" | SFD-0808AF Varex PaxScan 2020X (194µm) | Same as predicate |
| SIZE: 12" x 12" | SFD-1212AF Varex PaxScan 3030X (194µm) | Same as predicate |
| SIZE: 16" x 12" | SFD-1612AF Varex PaxScan 4030X (194µm) | Same as predicate |
| X-Ray Generation | ||
| Generator | 100 kW | Same as predicate |
| Model # | D150GC-40 | Same as predicate |
| Control Method | 50 kHz Inverter | Same as predicate |
| Rated output | 100 kW | Same as predicate |
| Radiography | ||
| tube Voltage | 40 kV- 150 kV | Same as predicate |
| Radiography | ||
| tube current | 10 to 1250 mA | Same as predicate |
| Radiography mAs | 0.5 to 800 mAs | Same as predicate |
| Radiography time | 0.001 to 10 sec | Same as predicate |
| Fluoroscopy tube | ||
| voltage | 50 kV to 125 kV | Same as predicate |
| Fluoroscopy tube | ||
| current | 0.3 to 38 mA | Same as predicate |
| Short time rating | 100 kV – 1000 mA | Same as predicate |
| Long time rating | 100 kV – 38mA | Same as predicate |
| Collimator | F-100: Has 16 BH filters with irridation area of | |
| 421 x 421 mm max. New collimator offers | ||
| more filtration options. | Same as predicate | |
| US Performance | ||
| Standard | 21CFR1020.30, 21CFR1020.31 and | |
| 21CFR2020.32 | Same as predicate | |
| IEC Safety | ||
| Standards | See list below | Same as predicate |
6. Substantial Equivalence Chart: Below.
5
6
-
- Summary of non-clinical testing: Software was validated according to the FDA Guidance: Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document issued on: May 11, 2005. Because the system uses Wi-Fi and Ethernet, we observed the recommendations contained in the FDA Guidance Document: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices Guidance for Industry and Food and Drug Administration Staff Document Issued on: October 2, 2014. The digital panel software employed was already reviewed by FDA. Labeling was developed and information provided in accordance with this FDA Guidance Document: Pediatric Information for X-ray Imaging Device Premarket Notifications, Guidance for Industry and Food and Druq Administration Staff, November 2017. Labeling also includes reference to the Image Gently website (http://www.imagegently.org/). Because the device contains wireless technology, we consulted Radio Frequency Wireless Technology in Medical Devices - Guidance for Industry and FDA Staff, AUGUST 2013 and we incorporated those recommendations into our labeling.
This device has been tested and is certified to comply with the US Radiation Safety Performance Standards as listed in the table above. Performance and safety testing was conducted by third party NRTL certified testing laboratories and the device was found to comply with the following FDA recognized standards:
- Summary of non-clinical testing: Software was validated according to the FDA Guidance: Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document issued on: May 11, 2005. Because the system uses Wi-Fi and Ethernet, we observed the recommendations contained in the FDA Guidance Document: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices Guidance for Industry and Food and Drug Administration Staff Document Issued on: October 2, 2014. The digital panel software employed was already reviewed by FDA. Labeling was developed and information provided in accordance with this FDA Guidance Document: Pediatric Information for X-ray Imaging Device Premarket Notifications, Guidance for Industry and Food and Druq Administration Staff, November 2017. Labeling also includes reference to the Image Gently website (http://www.imagegently.org/). Because the device contains wireless technology, we consulted Radio Frequency Wireless Technology in Medical Devices - Guidance for Industry and FDA Staff, AUGUST 2013 and we incorporated those recommendations into our labeling.
-
US Performance Standard: 21CFR1020.30, 21CFR1020.31 and 21CFR2020.32
-
IEC 60601-1: 2005 + CORR. 1:2006 + CORR. 2:2007 + AM1:2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance FDA 19-4
-
IEC 60601-1-2:2014 Collateral Standard: Electromagnetic disturbances Requirements and tests FDA . 19-8
-
IEC 60601-1-3:2008 + A1:2013 Medical electrical equipment - Part 1-3: General requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic Xray equipment FDA 12-269
-
IEC 60601-1-6:2010 + A1:2013 Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability FDA 5-89
-
. IEC 60601-2-43:2010 +A1:2017 +A2:2019 Particular requirements for the basic safety and essential performance of X-ray equipment for interventional procedures FDA 12-329
-
Additionally evaluated in accordance with
-
. IEC 62366: 2007 + A1: 2014 Medical devices - Part 1: Application of usability engineering to medical devices FDA 5-114
-
IEC 62304: 2006 Medical device software - Software life cycle processes FDA 13-79
-
EN 60601-1:2006 + A11:2011 + A1:2013 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance
-
EN 60601-1-3:2008 + A1:2013 + A11:2016 Medical electrical equipment Part 1-3: General ● requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic X-ray equipment
-
. EN 60601-1-6:2010 + A1:2015 Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability
-
. EN 60601-2-43:2010 + A1:2018 Medical electrical equipment - Particular requirements for the basic safety and essential performance of X-ray equipment for interventional procedures
-
EN 62304:2006 Medical device software - Software life cycle processes
-
ANSI/AAMI ES60601-1:2005 + A2:2010 + A1:2012 ●
7
We consulted the following FDA guidance documents in the development of the Trinias: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, Guidance for Industry and Food and Drug Administration Staff; and Pediatric Information for X-ray Imaging Device Premarket Notifications.
-
- Summary of clinical testing: Not applicable. Clinical testing was not deemed to show substantial equivalence. We relied on non-clinical testing and compliance with standards.
-
- Conclusion: After analyzing standards compliance results and bench tests, it is the conclusion of Shimadzu Corporation that the MODIFIED Trinias is as safe and effective as the predicate device, has few technological differences, and has the same indications for use, thus rendering it substantially equivalent to the predicate device.